Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Music therapy with a tobacco‑addiction nurse to help people with cancer quit smoking

Official title: Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer

Run by Institut du Cancer de Montpellier - Val d'Aurelle · NCT07198971 · Data updated 2026-11-12

This project will try whether personalized music therapy combined with support from a tobacco‑addiction nurse helps people with cancer who smoke reduce withdrawal symptoms and quit.

More Cancer (With or Without Metastasis) trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment26 (estimated)
SponsorInstitut du Cancer de Montpellier - Val d'Aurelle
Academic / other
Locations1 site (Montpellier, Herault)
StatusRecruiting
StartedFebruary 18, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedApril 9, 2026
Trial IDNCT07198971 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with solid‑tumor cancer (not hematologic), who smoke daily, want to begin a quitting programme, have a prognosis over one year, and can attend regular follow‑up are ideal candidates.

Probably not a fit

People with uncorrected hearing loss, unstable psychiatric conditions, inability to attend regular follow‑up, or who are under guardianship/curatorship are excluded and unlikely to benefit from this programme.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants work with a music therapist to co-create a personalised soundtrack and with a tobacco‑addiction nurse for smoking‑cessation support and therapeutic education. The programme teaches patients when and how to use their soundtrack to manage cravings and withdrawal in daily life. The intervention is delivered onsite at the cancer centre and patients are expected to use the music tool independently between sessions. The primary aim is to test feasibility and to collect initial data on effects on withdrawal symptoms and smoking behaviour.

Why it matters

Potential benefit: If successful, this approach could give patients a personalized, non‑pharmacologic tool that reduces withdrawal symptoms and increases the chances of quitting smoking.

How similar studies have gone: There is very limited prior research on music therapy for tobacco addiction in cancer patients, so this combined approach is largely novel with little direct supporting evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients over the age of 18
2. Patients with tobacco-related or non-tobacco-related cancer (excluding blood cancer)
3. Patients who smoke daily
4. Patients wishing to begin a smoking cessation programme
5. Patients with a prognosis of \> 1 year
6. Patients who have given their informed, written and express consent
7. Patients affiliated with a French social security scheme

Exclusion Criteria:

1. Patients with uncorrected hearing loss
2. Patients with unstable psychiatric conditions
3. Patients for whom regular follow-up is impossible for psychological, family, social or geographical reasons
4. Patients under guardianship, curatorship or judicial protection

Where it's running

  • Institut Du Cancer de Montpellier
    Montpellier, Herault, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.